The Global Antiviral Drugs Industry is on the brink of a robust growth phase, with projections indicating an impressive 3.9% average annual increase from 2023 to 2033. This anticipated surge is expected to catapult the market to a staggering US$89.68 billion by 2033, a remarkable increase from its 2023 valuation of US$61.42 billion. Antiviral drugs, …